98 related articles for article (PubMed ID: 33308842)
21. Assessing the lived experiences of females with phenylketonuria in their health management.
Aronoff A; Guan Y; Gurung S; Comeau DL; Singh RH
Mol Genet Metab Rep; 2024 Sep; 40():101095. PubMed ID: 38846519
[TBL] [Abstract][Full Text] [Related]
22. The Sage of Tea and the Inherited Metabolic Diseases.
Gao X; Chang R; Xu E; Ning Q; Du J
Altern Ther Health Med; 2024 Mar; 30(3):167-169. PubMed ID: 37856821
[TBL] [Abstract][Full Text] [Related]
23. Discussion on protein recommendations for supporting muscle and bone health in older adults: a mini review.
Groenendijk I; de Groot LCPGM; Tetens I; Grootswagers P
Front Nutr; 2024; 11():1394916. PubMed ID: 38840697
[TBL] [Abstract][Full Text] [Related]
24. Tyrosine supplementation for phenylketonuria.
Remmington T; Smith S
Cochrane Database Syst Rev; 2021 Jan; 1(1):CD001507. PubMed ID: 33427303
[TBL] [Abstract][Full Text] [Related]
25. Long-Term Metabolic Correction of Phenylketonuria by AAV-Delivered Phenylalanine Amino Lyase.
Tao R; Xiao L; Zhou L; Zheng Z; Long J; Zhou L; Tang M; Dong B; Yao S
Mol Ther Methods Clin Dev; 2020 Dec; 19():507-517. PubMed ID: 33335942
[TBL] [Abstract][Full Text] [Related]
26. Human milk oligosaccharide DSLNT and gut microbiome in preterm infants predicts necrotising enterocolitis.
Masi AC; Embleton ND; Lamb CA; Young G; Granger CL; Najera J; Smith DP; Hoffman KL; Petrosino JF; Bode L; Berrington JE; Stewart CJ
Gut; 2021 Dec; 70(12):2273-2282. PubMed ID: 33328245
[TBL] [Abstract][Full Text] [Related]
27. Phenylketonuria.
van Spronsen FJ; Blau N; Harding C; Burlina A; Longo N; Bosch AM
Nat Rev Dis Primers; 2021 May; 7(1):36. PubMed ID: 34017006
[TBL] [Abstract][Full Text] [Related]
28. Protein Substitutes in PKU; Their Historical Evolution.
Daly A; Evans S; Pinto A; Ashmore C; MacDonald A
Nutrients; 2021 Feb; 13(2):. PubMed ID: 33540516
[TBL] [Abstract][Full Text] [Related]
29. The effect of improved dietary control on cognitive and psychiatric functioning in adults with phenylketonuria: the ReDAPT study.
Burgess NM; Kelso W; Malpas CB; Winton-Brown T; Fazio T; Panetta J; De Jong G; Neath J; Atherton S; Velakoulis D; Walterfang M
Orphanet J Rare Dis; 2021 Jan; 16(1):35. PubMed ID: 33461585
[TBL] [Abstract][Full Text] [Related]
30. Nutrition status of adults with phenylketonuria treated with pegvaliase.
Viau K; Wessel A; Martell L; Sacharow S; Rohr F
Mol Genet Metab; 2021 Aug; 133(4):345-351. PubMed ID: 34116943
[TBL] [Abstract][Full Text] [Related]
31. Oxidative stress in phenylketonuria-evidence from human studies and animal models, and possible implications for redox signaling.
Bortoluzzi VT; Dutra Filho CS; Wannmacher CMD
Metab Brain Dis; 2021 Apr; 36(4):523-543. PubMed ID: 33580861
[TBL] [Abstract][Full Text] [Related]
32. Palynziq clinic: One year and 43 patients later.
Lah M; McPheron M
Mol Genet Metab; 2021 Jul; 133(3):250-256. PubMed ID: 34074593
[TBL] [Abstract][Full Text] [Related]
33. Tyrosine metabolism in health and disease: slow-release amino acids therapy improves tyrosine homeostasis in phenylketonuria.
Porta F; Giorda S; Ponzone A; Spada M
J Pediatr Endocrinol Metab; 2020 Dec; 33(12):1519-1523. PubMed ID: 33581706
[TBL] [Abstract][Full Text] [Related]
34. Protein status of people with phenylketonuria: a scoping review protocol.
Firman S; Ramachandran R; Whelan K; Witard OC; O'Keeffe M
BMJ Open; 2021 Sep; 11(9):e049883. PubMed ID: 34521668
[TBL] [Abstract][Full Text] [Related]
35. Retraction notice to "Sustaining benefits of nutritional therapy in young adults with phenylketonuria - A 2 year prospective study" [Molecular Genetics and Metabolism Reports 22 (2020) 100573].
Krämer J
Mol Genet Metab Rep; 2021 Jun; 27():100752. PubMed ID: 34168961
[TBL] [Abstract][Full Text] [Related]
36. Overweight/obesity in adolescents with phenylketonuria: protective and predisposing factors.
Silveira AM; Lima PL; Alves MRA; Soares RDL; Kanufre VC; Rodrigues VM; Starling ALP; Norton RC; Aguiar MJB
J Pediatr (Rio J); 2022; 98(1):104-110. PubMed ID: 34144002
[TBL] [Abstract][Full Text] [Related]
37. Identifying potential dietary treatments for inherited metabolic disorders using Drosophila nutrigenomics.
Martelli F; Lin J; Mele S; Imlach W; Kanca O; Barlow CK; Paril J; Schittenhelm RB; Christodoulou J; Bellen HJ; Piper MDW; Johnson TK
Cell Rep; 2024 Mar; 43(3):113861. PubMed ID: 38416643
[TBL] [Abstract][Full Text] [Related]
38. Total Protein Intake in Patients with PKU: Adequacy Evaluation According to the European PKU Guidelines from 2017.
Gomes M; Almeida MF; Barbosa CS; Gama MI; Peres M; Pinto É; MacDonald A; Rocha JC
Nutrients; 2023 Nov; 15(23):. PubMed ID: 38068741
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of a New 'Mix-In' Style Glycomacropeptide-Based Protein Substitute for Food and Drinks in Patients with Phenylketonuria and Tyrosinemia.
Delsoglio M; Capener R; MacDonald A; Daly A; Ashmore C; Donald S; Gaff L; VanDorp L; Skeath R; Ellerton C; Newby C; Dunning G; Dale C; Hunjan I; White L; Allen H; Hubbard GP; Stratton RJ
Nutrients; 2023 Aug; 15(16):. PubMed ID: 37630788
[TBL] [Abstract][Full Text] [Related]
40. Phenylalanine Tolerance over Time in Phenylketonuria: A Systematic Review and Meta-Analysis.
Pinto A; Ilgaz F; Evans S; van Dam E; Rocha JC; Karabulut E; Hickson M; Daly A; MacDonald A
Nutrients; 2023 Aug; 15(16):. PubMed ID: 37630696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
